Expertise: Clinical Development 64 results
Selecting Sites for Radiopharmaceutical Studies: A Checklist
Avoiding 3 Common Pitfalls to Efficient Site Selection
Selecting the right sites for a clinical trial is one of the most important determinants of successful clinical trial recruitment. In an increasingly competitive clinical trial environment where study designs have become more complex and sites are more selective about the studies they take on, sponsors and CROs are tasked with making the site selection…
On June 26, 2024, the U.S. Food and Drug Administration (FDA) released its much-anticipated draft guidance on clinical trial diversity.1 This 23-page document outlines proposed requirements for racial and ethnic diversity action plans, which will soon become mandatory for studies involving drugs, devices, and other medical products. In this article, we highlight the key provisions…
The Power of Clinical Data: Why Strategic PMCF Studies Matter
The Power of Clinical Data: Why Strategic PMCF Studies Matter
5 Essentials for Building a Robust Target Product Profile
A Target Product Profile (TPP) serves as the primary strategic framework that aligns commercial and clinical workstreams. When properly defined, the TPP enables drug developers to manage the development equation of risk x cost x time = success, and it starts by keeping the end in mind. Defining the needs of patients, physicians, and payers…